Maravai Lifesciences Holdings, Inc.

Maravai Lifesciences Holdings, Inc. (MRVI) priced its initial public offering on Nov 23, 2020 at $27.00 per share, raising $1.62B, and listed on Nasdaq Global Select. At the IPO price its market capitalization was about $6.96B. Kirkland & Ellis advised the company and Davis Polk advised the underwriters.

Maravai LifeSciences Holdings, Inc. provides products used in developing drug therapies, diagnostics and novel vaccines and in research on human diseases. Its more than 5,000 customers include top global biopharmaceutical companies, emerging life sciences firms and academic research institutions.

Status

IPO

Ticker

MRVI

Exchange

Nasdaq Global Select

Priced

Nov 23, 2020

IPO price

$27.00

Raised

$1.62B

Market cap at IPO price

$6.96B

First filed

Oct 29, 2020

Company counsel

Kirkland & Ellis

Underwriters' counsel

Davis Polk

Sector

Biotech & pharma

Country / state

CA

Market cap at IPO price = shares outstanding after the offering (all classes, before the over-allotment option) × the IPO price, from the final prospectus.